SAN DIEGO, Sept. 14 /PRNewswire-FirstCall/ -- ADVENTRX Pharmaceuticals, Inc.
today announced its intention to voluntarily withdraw the
listing of its common stock on the NYSE Amex. The Company has applied to list
its common stock on The NASDAQ Capital Market under the symbol "ADVX."
ADVENTRX's withdrawal from the NYSE Amex is conditioned on approval by The
NASDAQ Capital Market. The final timing of the anticipated change has not yet
been determined.
